Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe.
Trinity Biotech stock last closed at $0.55, up 7.84% from the previous day, and has decreased 57.03% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.43 percentage points. Trinity Biotech stock is currently +48.65% from its 52-week low of $0.37, and -57.36% from its 52-week high of $1.29.
There are currently 152.43M TRIB shares outstanding. The market capitalization of TRIB is $20.96M. In the past 24 hours, 38,204 TRIB shares were traded.
You need a brokerage account to access the NASDAQ market and buy TRIB shares.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal information so you can buy TRIB today.
Now that you have opened your account on the best stock app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring money into your new brokerage account.
Once you have selected the best place to buy Trinity Biotech stock, it's very important to evaluate their stock before you invest, so you truly understand the risk and opportunity.
WallStreetZen was built to help average investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on TRIB's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge TRIB's intrinsic value.
You can do more valuation analysis on TRIB's stock here.
You can dive deeper into what analysts are projecting on the Trinity Biotech stock forecast page.
Last year, TRIB revenue was $66.27M. Over the past 5 year, TRIB's revenue has gone up by -7.71% per year. This was slower than the Diagnostics & Research industry average of 13%.
Learn more about TRIB's earnings and revenue performance here.
In the past year, executives and large shareholders at TRIB have not bought or sold any shares.
Learn more about who owns TRIB stock here.
No, Trinity Biotech doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two main options:
Press the Open Trade button and eToro will place the order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
Now that you own some shares in TRIB, you'll want to keep up with your new stock purchase.
Make a watchlist to get alerted to the latest events about your TRIB stock.
To summarize, here are the 6 steps for buying Trinity Biotech stock:
If you require a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your new investment in Trinity Biotech, add TRIB to your watchlist below.